• Chinese medical journal · Dec 2020

    Efficacy and safety of decitabine combined with low-dose cytarabine, aclarubicin, and granulocyte colony-stimulating factor compared with standard therapy in acute myeloid leukemia patients with TP53 mutation: a single-center analysis.

    • Si-Si Chen, Qian Sun, Lan Cao, Wen-Zhong Wu, Yue Xie, Chun Qiao, Jian-Yong Li, Si-Xuan Qian, and Ming Hong.
    • Department of Hematology,The Affiliated Yixing Hospital of Jiangsu University, Wuxi, Jiangsu 214200, China.
    • Chin. Med. J. 2020 Dec 8; 134 (12): 147714791477-1479.

    no abstract available

      Pubmed     Free full text   Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        

    hide…